Skip to content
Search

Latest Stories

Revealed: Top 5 reasons why Brits avoid visiting doctors

Revealed: Top 5 reasons why Brits avoid visiting doctors

While self-testing can alleviate pressure on the NHS, more than a quarter of Brits mistakenly believe at-home tests require a prescription from a medical professional

Long appointment wait times, embarrassment, and lack of trust are causing thousands of Brits to avoid visiting doctors, according to new research by Newfoundland Diagnostics.


With 1 in 4 individuals resorting to A&E due to the lack of available GP appointments, which adds to the NHS burden, the medical self-testing brand believes that educating the nation on at-home testing can help ease the strain on the health service.

The research revealed the top five reasons why Brits avoid visiting doctors for medical testing:

  1. Appointments taking too long to book (28 per cent)
  2. Embarrassment around their illnesses (15 per cent)
  3. Preference for at-home testing (12 per cent)
  4. Not having time (10 per cent)
  5. Lack of trust in the NHS or their GP (7 per cent)

The research team cautioned that delaying care can worsen conditions, resulting in more severe cases that place greater strain on the NHS.

Newfoundland Diagnostics, a leading UK provider of diagnostic tests and medical devices, aims to alleviate this burden by encouraging nationwide testing. The organisation believes that by enabling individuals to easily gather data at home, self-testing can help reduce unnecessary doctor visits and ensure patients are well-informed when seeking quality care.

While self-testing became popular during the COVID-19 pandemic, there remain significant educational gaps that need to be addressed, the company stated.

Newfoundland Diagnostics’ research also found that over a quarter of Brits believe that at-home tests require a prescription from a medical professional, even though these tests are readily available in major supermarkets and pharmacies across the UK.

This misconception is even more prevalent among men, with more than 1 in 3 believing that self-tests cannot be purchased over the counter, compared to 23 per cent of women.

The research further indicates that younger Brits, particularly those aged 16-24, need better education on healthcare access, as nearly half of them think at-home tests must be prescribed, compared to less than 1 in 5 of those 55 and older.

"It’s surprising how many across the country believe that at-home testing is inaccessible despite their ubiquity during the pandemic,” said Frederick Manduca, co-founder of Newfoundland Diagnostics.

Meanwhile, renowned GP and broadcaster Dr Hilary Jones has joined the company in an advisory role to educate the nation on testing at home to help ease the strain on the NHS.

He believes self-testing can help overcome the barriers preventing people from seeking medical care.

Dr Jones said: "At-home testing has the potential to be a game-changer for easing the strain on our NHS, but we need more Brits to embrace self-testing.

"By empowering people to routinely monitor their health and identify issues early, we can significantly reduce unnecessary GP and A&E visits for conditions that could be caught sooner through self-testing. This frees up critical medical resources for those most in need of urgent care.”

Dr Jones elaborated that self-tests provide patients with key diagnostic information, which they can share with their doctor for more informed, effective treatment plans.

He highlighted that detecting issues like high cholesterol, fertility problems or potential cancers at an earlier stage leads to better health outcomes and could potentially saving lives.

Manduca expressed that Dr. Hilary's advisory role would be invaluable in empowering the nation to embrace their easy-to-use, affordable at-home tests as “a pathway to accessible healthcare”, emphasising that early identification can be life-saving.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less